Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 11037
Gene Symbol: STON1
STON1
0.010 GeneticVariation disease BEFREE Since these activities likely extend to the entire ALF protein family, this study also significantly inputs our understanding of the molecular basis of FRAXE mental retardation syndrome in which FMR2 expression is silenced. 17135274 2007
Entrez Id: 286749
Gene Symbol: STON1-GTF2A1L
STON1-GTF2A1L
0.010 GeneticVariation disease BEFREE Since these activities likely extend to the entire ALF protein family, this study also significantly inputs our understanding of the molecular basis of FRAXE mental retardation syndrome in which FMR2 expression is silenced. 17135274 2007
Entrez Id: 173
Gene Symbol: AFM
AFM
0.010 GeneticVariation disease BEFREE Since these activities likely extend to the entire ALF protein family, this study also significantly inputs our understanding of the molecular basis of FRAXE mental retardation syndrome in which FMR2 expression is silenced. 17135274 2007
Entrez Id: 11036
Gene Symbol: GTF2A1L
GTF2A1L
0.010 GeneticVariation disease BEFREE Since these activities likely extend to the entire ALF protein family, this study also significantly inputs our understanding of the molecular basis of FRAXE mental retardation syndrome in which FMR2 expression is silenced. 17135274 2007
Entrez Id: 84162
Gene Symbol: KIAA1109
KIAA1109
0.010 Biomarker disease BEFREE FRAXE (FMR2) is a fragile site associated with mental impairment located in Xq28, 600 kb distal to FRAXA (FMR1), the fragile X syndrome fragile site. 11462240 2001
Entrez Id: 2477
Gene Symbol: FRAXA
FRAXA
0.010 PosttranslationalModification disease BEFREE Similar to FRAXA, expansion of the GCC repeats results in an abnormal methylation of the CpG island and is associated with a mild mental retardation syndrome (FRAXE-MR). 8844095 1996
Entrez Id: 2481
Gene Symbol: FRAXE
FRAXE
0.060 GeneticVariation disease BEFREE Our observation demonstrates that FMR2 gene deletions may contribute to the FRAXE phenotype. 21739600 2011
Entrez Id: 2481
Gene Symbol: FRAXE
FRAXE
0.060 AlteredExpression disease BEFREE It is possible that other members of the AFF family compensate for the loss of AFF2/FMR2 activity and as such explain the relatively mild to borderline phenotype observed in FRAXE patients. 21330300 2011
Entrez Id: 2481
Gene Symbol: FRAXE
FRAXE
0.060 AlteredExpression disease BEFREE Since these activities likely extend to the entire ALF protein family, this study also significantly inputs our understanding of the molecular basis of FRAXE mental retardation syndrome in which FMR2 expression is silenced. 17135274 2007
Entrez Id: 2481
Gene Symbol: FRAXE
FRAXE
0.060 GeneticVariation disease BEFREE FRAXE syndrome is rare, and patients' phenotypes are highly variable, leading to difficulties with predicting specific FMR2 functions based on the human disease. 14526173 2003
Entrez Id: 2481
Gene Symbol: FRAXE
FRAXE
0.060 Biomarker disease BEFREE FRAXE (FMR2) is a fragile site associated with mental impairment located in Xq28, 600 kb distal to FRAXA (FMR1), the fragile X syndrome fragile site. 11462240 2001
Entrez Id: 2481
Gene Symbol: FRAXE
FRAXE
0.060 GeneticVariation disease BEFREE Standardized cognitive, behavioral, and neuroanatomical data are presented on 2 unrelated boys with the FRAXE (FMR2) GCC expansion mutation. 9034011 1997
Entrez Id: 5265
Gene Symbol: SERPINA1
SERPINA1
0.100 CausalMutation disease CLINVAR
Entrez Id: 351
Gene Symbol: APP
APP
0.300 Therapeutic disease CTD_human Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice. 22046307 2011
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.310 Biomarker disease CTD_human Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety. 28616095 2017
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.310 Biomarker disease CTD_human Fragile x syndrome. 22043169 2011
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.310 Biomarker disease CTD_human GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. 20300527 2010
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.310 Biomarker disease CTD_human Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. 18835858 2009
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.310 Biomarker disease CTD_human Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome. 17065172 2006
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.310 Biomarker disease CTD_human Fragile X mental retardation protein shifts between polyribosomes and stress granules after neuronal injury by arsenite stress or in vivo hippocampal electrode insertion. 16510718 2006
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.310 Biomarker disease CTD_human Fragile X-associated tremor/ataxia syndrome presenting in a woman after chemotherapy. 16043816 2005
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.310 Biomarker disease CTD_human Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. 15028757 2004
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.310 GeneticVariation disease BEFREE The aims of this population screening were to determine the prevalence of FRAXA and FRAXE syndromes among idiopathic mentally retarded (IMR) individuals, to estimate the incidence in the general population, and to investigate the molecular mechanism of instability and expansion of the FMR1-repeat. 10331587 1999
Entrez Id: 2334
Gene Symbol: AFF2
AFF2
0.740 Biomarker disease CLINGEN Loss of FMR2 further emphasizes the link between deregulation of immediate early response genes FOS and JUN and intellectual disability. 23562910 2013
Entrez Id: 2334
Gene Symbol: AFF2
AFF2
0.740 AlteredExpression disease BEFREE It is possible that other members of the AFF family compensate for the loss of AFF2/FMR2 activity and as such explain the relatively mild to borderline phenotype observed in FRAXE patients. 21330300 2011